当前位置:首页 - 行情中心 - 新华制药(000756) - 财务分析 - 现金流量表

新华制药

(000756)

  

流通市值:65.75亿  总市值:91.82亿
流通股本:4.99亿   总股本:6.97亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,596,498,240.081,873,080,879.597,821,587,287.235,759,173,328.3
  收到的税费返还35,598,073.4718,065,843.3262,621,737.0957,238,889.51
  收到其他与经营活动有关的现金16,456,280.3825,175,301.4947,618,648.1441,299,954.1
  经营活动现金流入小计3,648,552,593.931,916,322,024.47,931,827,672.465,857,712,171.91
  购买商品、接受劳务支付的现金2,652,766,111.371,565,015,221.765,634,520,638.324,252,434,435.68
  支付给职工以及为职工支付的现金500,099,699.85244,464,892.121,006,072,823.4763,390,417.43
  支付的各项税费129,459,774.2284,246,612.02205,120,205.35170,288,449.73
  支付其他与经营活动有关的现金205,611,203.49139,148,001.59552,385,297.65349,600,006.1
  经营活动现金流出小计3,487,936,788.932,032,874,727.497,398,098,964.725,535,713,308.94
  经营活动产生的现金流量净额160,615,805-116,552,703.09533,728,707.74321,998,862.97
二、投资活动产生的现金流量:
  取得投资收益收到的现金--9,799,737.768,515,076.8
  处置固定资产、无形资产和其他长期资产收回的现金净额740,290735,300768,995.95735,731.49
  收到的其他与投资活动有关的现金217,900109,4001,529,792.061,473,780
  投资活动现金流入小计958,190844,70012,098,525.7710,724,588.29
  购建固定资产、无形资产和其他长期资产支付的现金39,676,826.4727,430,037.86115,602,127.29103,668,229.93
  支付其他与投资活动有关的现金---3,000,000
  投资活动现金流出小计39,676,826.4727,430,037.86115,602,127.29106,668,229.93
  投资活动产生的现金流量净额-38,718,636.47-26,585,337.86-103,503,601.52-95,943,641.64
三、筹资活动产生的现金流量:
  吸收投资收到的现金48,340,450.548,340,450.556,172,46155,577,524.5
  其中:子公司吸收少数股东投资收到的现金--3,000,000-
  取得借款收到的现金500,000,000280,000,000979,800,000749,800,000
  收到其他与筹资活动有关的现金33,000,00033,000,0005,260,0005,260,000
  筹资活动现金流入小计581,340,450.5361,340,450.51,041,232,461810,637,524.5
  偿还债务支付的现金569,510,606.06342,000,0001,111,677,569.79842,677,569.79
  分配股利、利润或偿付利息支付的现金18,625,104.956,895,211.3218,762,051.81210,599,035.03
  其中:子公司支付给少数股东的股利、利润--8,982,0008,982,000
  支付其他与筹资活动有关的现金1,075,171.1642,587.551,921,057.421,477,894.87
  筹资活动现金流出小计589,210,882.11349,537,798.851,332,360,679.021,054,754,499.69
  筹资活动产生的现金流量净额-7,870,431.6111,802,651.65-291,128,218.02-244,116,975.19
四、汇率变动对现金及现金等价物的影响-6,873,784.582,343,164.687,237,015.536,124,226.96
五、现金及现金等价物净增加额107,152,952.34-128,992,224.62146,333,903.73-11,937,526.9
  加:期初现金及现金等价物余额1,283,208,913.791,283,208,913.791,136,875,010.061,136,875,010.06
  期末现金及现金等价物余额1,390,361,866.131,154,216,689.171,283,208,913.791,124,937,483.16
补充资料:
  净利润147,954,793.02-306,303,918.15-
  资产减值准备40,425,032.15-47,394,139.35-
  固定资产和投资性房地产折旧266,927,202.93-512,529,806.51-
  无形资产摊销38,247,541.62-73,577,903.29-
  长期待摊费用摊销1,141,708.61-4,347,764.33-
  处置固定资产、无形资产和其他长期资产的损失-93,383.69--1,990,589.09-
  固定资产报废损失1,472,922.14-1,043,407.59-
  财务费用24,138,248.01-35,194,311.86-
  投资损失-7,472,191.62--7,764,521.27-
  递延所得税-3,174,809.21--315,974.22-
  其中:递延所得税资产减少1,759,820.51-3,730,000.74-
    递延所得税负债增加-4,934,629.72--4,045,974.96-
  存货的减少-18,352,287.91--92,833,245.57-
  经营性应收项目的减少-238,014,302.11--547,754,132.8-
  经营性应付项目的增加-100,782,781.98-184,716,546.76-
  其他1,162,038.3-12,517,620.5-
  现金的期末余额1,390,361,866.13-1,283,208,913.79-
  减:现金的期初余额1,283,208,913.79-1,136,875,010.06-
  现金及现金等价物的净增加额107,152,952.34-146,333,903.73-
公告日期2026-08-262026-04-292026-03-302025-10-25
审计意见(境内)标准无保留意见
TOP↑